Advertisement
ALGN vs TMDX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Buy and TMDX is a Buy.
Momentum Indicator for ALGN turns positive, indicating new upward trend
ALGN saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned positive. In 63 of the 80 cases, the stock moved higher in the following days. The odds of a move higher are at 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on October 08, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in 29 of 41 cases over the following month. The odds of a continued upward trend are 71%.
ALGN moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ALGN crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 36%.
Following a +9.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in 187 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 153 of 206 cases where ALGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
Bearish Trend Analysis
The 10-day RSI Indicator for ALGN moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 17 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
ALGN broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 23 (best 1 - 100 worst), indicating outstanding price growth. ALGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.786) is normal, around the industry mean (4.964). P/E Ratio (28.769) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.611) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.612) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
TMDX's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for TMDX turned positive on November 04, 2026. Looking at past instances where TMDX's MACD turned positive, the stock continued to rise in 43 of 49 cases over the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on TMDX as a result. In 76 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
TMDX moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +35.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMDX advanced for three days, in 254 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
TMDX broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TMDX entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. TMDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.906) is normal, around the industry mean (4.142). P/E Ratio (19.829) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.709) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (5.033) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
ALGN | TMDX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 44 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 63 Fair valued | 70 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 65 | |
SMR RATING 1..100 | 69 | 28 | |
PRICE GROWTH RATING 1..100 | 23 | 41 | |
P/E GROWTH RATING 1..100 | 38 | 92 | |
SEASONALITY SCORE 1..100 | 5 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALGN's Valuation (63) in the Medical Specialties industry is in the same range as TMDX (70). This means that ALGN’s stock grew similarly to TMDX’s over the last 12 months.
TMDX's Profit vs Risk Rating (65) in the Medical Specialties industry is somewhat better than the same rating for ALGN (100). This means that TMDX’s stock grew somewhat faster than ALGN’s over the last 12 months.
TMDX's SMR Rating (28) in the Medical Specialties industry is somewhat better than the same rating for ALGN (69). This means that TMDX’s stock grew somewhat faster than ALGN’s over the last 12 months.
ALGN's Price Growth Rating (23) in the Medical Specialties industry is in the same range as TMDX (41). This means that ALGN’s stock grew similarly to TMDX’s over the last 12 months.
ALGN's P/E Growth Rating (38) in the Medical Specialties industry is somewhat better than the same rating for TMDX (92). This means that ALGN’s stock grew somewhat faster than TMDX’s over the last 12 months.
| ALGN | TMDX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 1 day ago 79% |
| Stochastic ODDS (%) | 1 day ago 79% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 79% | 1 day ago 85% |
| MACD ODDS (%) | 3 days ago 71% | 1 day ago 88% |
| TrendWeek ODDS (%) | 1 day ago 73% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 72% | 1 day ago 85% |
| Advances ODDS (%) | 3 days ago 70% | 3 days ago 84% |
| Declines ODDS (%) | 16 days ago 76% | 15 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 85% |
| Aroon ODDS (%) | 1 day ago 74% | 1 day ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALGN’s FA Score shows that 1 FA rating(s) are green while TMDX’s FA Score has 1 green FA rating(s).
- ALGN’s FA Score: 1 green, 4 red.
- TMDX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALGN’s TA Score shows that 6 TA indicator(s) are bullish while TMDX’s TA Score has 4 bullish TA indicator(s).
- ALGN’s TA Score: 6 bullish, 4 bearish.
- TMDX’s TA Score: 4 bullish, 5 bearish.
Price Growth
ALGN (@Pharmaceuticals: Other) experienced а +4.35% price change this week, while TMDX (@Medical/Nursing Services) price change was +26.47% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.07%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was +22.77%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.
Reported Earning Dates
ALGN is expected to report earnings on Feb 03, 2027.
TMDX is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Pharmaceuticals: Other (+2.07% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-2.76% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ALGN and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALGN has been closely correlated with NVST. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALGN jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To ALGN | 1D Price Change % | ||
|---|---|---|---|---|
| ALGN | 100% | -1.25% | ||
| NVST - ALGN | 71% Closely correlated | -2.01% | ||
| XRAY - ALGN | 59% Loosely correlated | +0.62% | ||
| ICUI - ALGN | 54% Loosely correlated | -2.11% | ||
| LUNG - ALGN | 52% Loosely correlated | +6.43% | ||
| SOLV - ALGN | 50% Loosely correlated | -1.62% | ||
More | ||||
TMDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with ATEC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then ATEC could also see price increases.
| Ticker / NAME | Correlation To TMDX | 1D Price Change % | ||
|---|---|---|---|---|
| TMDX | 100% | +1.17% | ||
| ATEC - TMDX | 37% Loosely correlated | +5.00% | ||
| RDNT - TMDX | 35% Loosely correlated | +0.18% | ||
| SMTI - TMDX | 34% Loosely correlated | -0.16% | ||
| ALGN - TMDX | 33% Loosely correlated | -1.25% | ||
| PODD - TMDX | 32% Poorly correlated | +1.33% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AQLT | 31.73 | 0.34 | +1.08% |
| iShares MSCI Global Quality Factor ETF (AQLT) | |||
| GXPC | 27.47 | 0.21 | +0.77% |
| Global X PureCap MSCI Communication Services ETF (GXPC) | |||
| PSET | 79.91 | N/A | N/A |
| Principal Quality ETF (PSET) | |||
| KBE | 66.67 | -0.12 | -0.18% |
| State Street SPDR S&P Bank ETF (KBE) | |||
| APHU | 22.15 | -0.26 | -1.16% |
| T-REX 2X Long APH Daily Target ETF (APHU) | |||